-
Burkinabe teen behind viral French 'coup' video has no regrets
-
Brazil court rejects new Bolsonaro appeal against coup conviction
-
Three-time Grand Slam winner Wawrinka to retire in 2026
-
Man Utd can fight for Premier League title in next few years: Amorim
-
Pandya blitz powers India to T20 series win over South Africa
-
Misinformation complicated Brown University shooting probe: police
-
IMF approves $206 mn aid to Sri Lanka after Cyclone Ditwah
-
Stocks advance as markets cheer weak inflation
-
Emery says rising expectations driving red-hot Villa
-
Three killed in Taipei metro attacks, suspect dead
-
Seven Colombian soldiers killed in guerrilla attack: army
-
Amorim takes aim at Man Utd youth stars over 'entitlement'
-
Mercosur meets in Brazil, EU eyes January 12 trade deal
-
US Fed official says no urgency to cut rates, flags distorted data
-
Rome to charge visitors for access to Trevi Fountain
-
Spurs 'not a quick fix' for under-fire Frank
-
Poland president accuses Ukraine of not appreciating war support
-
Stocks advance with focus on central banks, tech
-
Amorim unfazed by 'Free Mainoo' T-shirt ahead of Villa clash
-
PSG penalty hero Safonov ended Intercontinental win with broken hand
-
French court rejects Shein suspension
-
'It's so much fun,' says Vonn as she milks her comeback
-
Moscow intent on pressing on in Ukraine: Putin
-
UN declares famine over in Gaza, says 'situation remains critical'
-
Guardiola 'excited' by Man City future, not pondering exit
-
Czechs name veteran coach Koubek for World Cup play-offs
-
PSG penalty hero Safonov out until next year with broken hand
-
Putin says ball in court of Russia's opponents in Ukraine talks
-
Czech Zabystran upsets Odermatt to claim Val Gardena super-G
-
NGOs fear 'catastrophic impact' of new Israel registration rules
-
US suspends green card lottery after MIT professor, Brown University killings
-
Arsenal in the 'right place' as Arteta marks six years at club
-
Sudan's El-Fasher under the RSF, destroyed and 'full of bodies'
-
From farms to court, climate-hit communities take on big polluters
-
Liverpool have 'moved on' from Salah furore, says upbeat Slot
-
Norway crown princess likely to undergo lung transplant
-
Iraq negotiates new coalition under US pressure
-
France's budget hits snag in setback for embattled PM
-
Putin hails Ukraine gains, threatens more, in annual press conference
-
US suspends green card lottery after Brown, MIT professor shootings
-
Chelsea's Maresca says Man City link '100 percent' speculation
-
Dominant Head moves into Bradman territory with fourth Adelaide ton
-
Arsenal battle to stay top of Christmas charts
-
Mexican low-cost airlines Volaris and Viva agree to merger
-
Border casinos caught in Thailand-Cambodia crossfire
-
Australia's Head slams unbeaten 142 to crush England's Ashes hopes
-
Epstein files due as US confronts long-delayed reckoning
-
'Not our enemy': Rush to rearm sparks backlash in east Germany
-
West Indies 110-0, trail by 465, after Conway's epic 227 for New Zealand
-
Arsonists target Bangladesh newspapers after student leader's death
Featured
Last news
Protagonist Announces New Icotrokinra Data in Ulcerative Colitis Showing Potential for a Standout Combination of Therapeutic Benefit and a Favorable Safety Profile in Once-daily Pill
Icotrokinra met the primary endpoint of clinical response at all three doses, with 36.5% of patients treated achieving endoscopic improvement and 30.2% achieving clinical remission at the highest dose at Week 12 in the Phase 2b ANTHEM-UC studyThese data support the promise of a first-in-class targeted oral peptide that selectively blocks the IL-23 receptor as a potential new option for people with moderately to severely active ulcerative colitisRegistrational Phase 3 study in ulcerative colitis and Phase 2b/3 study in Crohn's disease anticipated to begin patient enrollment in Q4 2025
Telomir Pharmaceuticals Announces New Findings in a Prostate Cancer Model Demonstrating Telomir-1 Also Resets DNA Methylation of Tumor Suppressor Genes Implicated in Two of the Most Persistent Challenges in Oncology-Metastasis and Treatment Resistance
Findings show that Telomir-1 restores the body's natural tumor suppressor defenses by reversing abnormal DNA methylation of MASPIN and RASSF1A - genes that help block invasion, limit metastasis, and improve chemotherapy responsiveness in aggressive prostate cancer models.
Medicus Pharma Ltd. to Present at the Family Office Summit in Dubai, UAE
EXECUTIVE CHAIRMAN & CEO OF MEDICUS TO PARTICIPATE IN A PANEL DISCUSSIONThe Summit theme "unlocking the $1 Trillion Wealth transfer in Dubai"
Desert Oasis Healthcare Recognizes American Pharmacists Month
Celebrating the vital role pharmacists play in patient health
The 7 Virtues Launches Buttercream Haze, The Rebel Gourmand
Brand welcomes new leaders Lori Wachs and Hope Bonneville, grows to 2,100 Sephora doors globally, and debuts its boldest gourmand yet
Las Vegas, Are You Ready for the Hoedown of the Year?
Compassion Center Hosts its Coalition for Patient Rights' First-Ever Charity Hoedown - $1 Admission for a Full Day of Fun at the Paradise Recreation Center
Sales of Licensed Branded Consumer Products Grow 3.4% to Reach $79.3 Billion in Europe, Outpacing Inflation
Licensing International and Circana insights reveal strong resilience and consumer demand for products and experiences aligned with popular brands.License Global's annual Leading Licensors whitepaper highlights top brands driving growth including Disney, NBCUniversal and Pokémon.
Trump says may invoke Insurrection Act to deploy more troops in US
President Donald Trump threatened Monday to use emergency powers against rebellion to deploy more troops into Democratic-led US cities, intensifying his rhetoric as his attempts to mobilize the military face legal challenges.
Hamas and Israel open talks in Egypt under Trump's Gaza peace plan
Delegations from Hamas and Israel on Monday began indirect talks in Egypt's Sharm El-Sheikh on ending the nearly two-year war in Gaza, under a plan put forward by US President Donald Trump.
ICC finds Sudan militia chief guilty of crimes against humanity
The International Criminal Court (ICC) on Monday convicted a feared Sudanese militia chief for war crimes and crimes against humanity committed during brutal attacks in Darfur.
One hiker dead, hundreds rescued after heavy snowfall in China
One hiker died and hundreds of others were rescued after sudden heavy snowfall on the Tibetan Plateau and near Mount Everest on the Chinese side, state media and hikers reported on Monday.
UK queen pays tribute to author Jilly Cooper, dead at 88
The UK's Queen Camilla on Monday led tributes to British author Jilly Cooper, known for her unapologetically raunchy romance novels, who has died at the age of 88 following a fall.
Streaming stars' Le Mans race scores Twitch viewer record
A race between 24 top streamers in Formula 4 cars in Le Mans, France was watched by 1.4 million people on the Twitch platform and almost as many on television.
Leopard captured after wandering into Indonesian hotel
A leopard was captured on Monday after it wandered into a hotel complex in one of Indonesia's most popular holiday destinations, sparking panic among guests.
Rescuers scramble to deliver aid after deadly Nepal, India floods
Rescuers in Nepal and India on Monday scrambled to deliver emergency aid after days of torrential rain triggered landslides and floods that have killed more than 70 people, officials said.
Australia prosecutors appeal 'inadequate' sentence for mushroom murderer: media
Australian prosecutors said Monday they had launched an appeal against last month's "manifestly inadequate" sentence for convicted murderer Erin Patterson, local media reported, after a trial that drew global attention.
ICC to give war crimes verdict on Sudan militia chief
The International Criminal Court (ICC) on Monday hands down its verdict on a feared Sudanese militia chief accused of war crimes and crimes against humanity during brutal attacks in Darfur.
Only man to appeal in Gisele Pelicot case says not a 'rapist'
Husamettin Dogan, the only man left appealing his conviction for sexually abusing Gisele Pelicot, is hoping to rid himself of the label of rapist when he steps back into court in France on Monday.
Gisele Pelicot: French rape survivor and global icon
Gisele Pelicot, 72, who became an icon for women in a mass rape trial last year that resonated around the world, is to reluctantly break months of silence to face in court the one man in the case who still denies he raped her.
New to The Street to Broadcast Tonight on Fox Business 10:30 PM PST Featuring NeOnc Technologies, FLOKI, XION, Sharps Technology, and Aeries Technology
NEW YORK CITY, NEW YORK / ACCESS Newswire / October 6, 2025 / New to The Street, one of America's longest-running business television brands, announces tonight's nationwide broadcast on Fox Business at 10:30 PM PST. The episode features exclusive interviews with NeOnc Technologies (NASDAQ:NTHI), FLOKI, XION, Sharps Technology (NASDAQ:STSS), and Aeries Technology (NASDAQ:AERT), each highlighting their innovation, growth, and leadership in their respective sectors.
Pèppoli at Pebble Beach Celebrates 25 Years with Michelin Guide Recommendation in California 2025 Selection
Beloved Tuscan-inspired restaurant marks milestone year with recognition for culinary excellence and authenticity
DEA Marijuana Cruelty Disguised as Process: Will President Trump Stop Delay on Cannabis Medicine For Huntington's and MS Patients
For seven years, a critical application to grow cannabis for FDA approved medicine has languished at the Drug Enforcement Administration (DEA), sparking allegations that the agency is in "blatant violation of federal law" and blocking potential treatments for thousands of patients battling Huntington's Disease (HD) and Multiple Sclerosis (MS).
International Pool Spa Patio Expo Converges Industry Leaders for Education and Product Exploration
Enhancement of pre-show matchmaking platform streamlines attendee preparation, reducing planning time while maximizing on-site impact.
Deck Expo 2025 Returns to Las Vegas to Showcase Tomorrow's Outdoor Living Innovations
Enhancement of pre-show matchmaking platform streamlines attendee preparation, reducing planning time while maximizing on-site impact.
Gaston Community Foundation Presents 35th Annual Allen H. Sims Award
Celebrates 25th Anniversary of the Next Generation Giving Circle.
Medical Care Technologies (OTC PINK:MDCE) Launches Next-Generation AI Validation Program Targeting Clinical-Grade Accuracy
MESA, AZ / ACCESS Newswire / October 6, 2025 / Medical Care Technologies Inc. (OTC Pink:MDCE) announced its plan to benchmark its upcoming AI diagnostic model against the HAM10000 public dermatology dataset to validate its image recognition architecture for detecting various skin lesion types.
Jaguar Health Completes Meeting with FDA for Advice on Development Pathways to Advance Ongoing Crofelemer Trial for Potential Approval for Treatment of Pediatric Indication Microvillus Inclusion Disease (MVID)
Additional update: Results of ongoing investigator-initiated proof-of-concept trial in United Arab Emirates (UAE) demonstrate further reduction of total parenteral support (PS) (comprised of total parenteral nutrition and supplementary IV fluids) of approximately 37%
Aspire Biopharma Holdings, Inc. Announces Filing of Omnibus Patent Application for Its Innovative Sublingual Drug Delivery Platform
ESTERO, FLORIDA / ACCESS Newswire / October 6, 2025 / Aspire Biopharma Holdings, Inc. (Nasdaq:ASBP) ("Aspire" or the "Company"), developer of a multi-faceted patent-pending drug delivery technology, today announced the filing of an omnibus patent application with the U.S. Patent and Trademark Office for its sublingual delivery technology. This application - which seeks patent protection of Aspire's proprietary technology in a variety of classes of drugs and other substances--focuses exclusively on protecting the Company's advanced sublingual drug delivery system, which is designed to enhance the pharmacokinetic performance of Active Pharmaceutical Ingredients ("APIs") and other substances into the bloodstream, increasing bioavailability and improving speed of onset.
Modular Medical Appoints David Bosshard to Lead its International Expansion for the Pivot Insulin Delivery System
-Seasoned Executive with Proven Track Record in International Pump Launches to Accelerate Global Adoption of User Friendly, Affordable Patch Pumps
AlEn USA Launches Activation with Kroger to Celebrate Hispanic Heritage Month
Mexican Cleaning Brand to Be Showcased in 250 Kroger Locations
Apex Health Names Peter J. Kelly as President
Seasoned value-based care leader joins Apex to accelerate growth and deepen health system partnerships
Mosaic Announces Completion of Sale of Phosphate Mining Unit in Brazil to Fosfatados Centro
TAMPA, FL, DC / ACCESS Newswire / October 6, 2025 / The Mosaic Company (NYSE:MOS) announced today the completion of its previously announced transaction with Fosfatados Centro SPE Ltda. ("Fosfatados Centro") for the sale of its idled Patos de Minas phosphate mining unit in Brazil. Under terms of the final deal, Fosfatados Centro will assume responsibility for the mine and tailings dams in Patos de Minas, paying Mosaic USD $111 million in cash, with $51 million paid at closing and the balance of the purchase price to be paid in installments over the next four years. Mosaic expects to record a book gain related to the transaction of $80-90 million in the fourth quarter of 2025.